[DCTP(II) combination chemotherapy of adult acute nonlymphocytic leukemia]. 1988

T Kobayashi, and M Ogawa, and Y Kuraishi, and T Nagata, and K Aiba, and T Nakamura, and N Usui, and H Yamazaki, and K Ichiba, and Y Isogai

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

T Kobayashi, and M Ogawa, and Y Kuraishi, and T Nagata, and K Aiba, and T Nakamura, and N Usui, and H Yamazaki, and K Ichiba, and Y Isogai
December 1985, Nihon Gan Chiryo Gakkai shi,
T Kobayashi, and M Ogawa, and Y Kuraishi, and T Nagata, and K Aiba, and T Nakamura, and N Usui, and H Yamazaki, and K Ichiba, and Y Isogai
August 1990, Gan to kagaku ryoho. Cancer & chemotherapy,
T Kobayashi, and M Ogawa, and Y Kuraishi, and T Nagata, and K Aiba, and T Nakamura, and N Usui, and H Yamazaki, and K Ichiba, and Y Isogai
November 1993, Chinese medical journal,
T Kobayashi, and M Ogawa, and Y Kuraishi, and T Nagata, and K Aiba, and T Nakamura, and N Usui, and H Yamazaki, and K Ichiba, and Y Isogai
May 1984, The Medical clinics of North America,
T Kobayashi, and M Ogawa, and Y Kuraishi, and T Nagata, and K Aiba, and T Nakamura, and N Usui, and H Yamazaki, and K Ichiba, and Y Isogai
November 1984, Blood,
T Kobayashi, and M Ogawa, and Y Kuraishi, and T Nagata, and K Aiba, and T Nakamura, and N Usui, and H Yamazaki, and K Ichiba, and Y Isogai
April 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
T Kobayashi, and M Ogawa, and Y Kuraishi, and T Nagata, and K Aiba, and T Nakamura, and N Usui, and H Yamazaki, and K Ichiba, and Y Isogai
September 1984, Mayo Clinic proceedings,
T Kobayashi, and M Ogawa, and Y Kuraishi, and T Nagata, and K Aiba, and T Nakamura, and N Usui, and H Yamazaki, and K Ichiba, and Y Isogai
November 1977, Cancer treatment reports,
T Kobayashi, and M Ogawa, and Y Kuraishi, and T Nagata, and K Aiba, and T Nakamura, and N Usui, and H Yamazaki, and K Ichiba, and Y Isogai
February 1976, Clinical pharmacology and therapeutics,
T Kobayashi, and M Ogawa, and Y Kuraishi, and T Nagata, and K Aiba, and T Nakamura, and N Usui, and H Yamazaki, and K Ichiba, and Y Isogai
July 1973, Cancer,
Copied contents to your clipboard!